Transcriptomic profiling of HepaRG cells with or without fat-loading
Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
PROVIDER: GSE185169 | GEO | 2024/01/01
REPOSITORIES: GEO
Similar Datasets
Project description:Transcriptomic profiling of HepaRG cells with or without fat-loading
| PRJNA767858 | ENA
Project description:Through scRNA-sequencing of primary human hepatocytes (PHHs), we have identified four subgroups of hepatocytes. A phenotyping 5-probe cocktail (Sanofi-Aventis) has been used to assess their metabolic capacity. Upon cocktail treatment, the characterized four hepatocyte subgroups displayed differential gene expression profiles and exhibited xenobiotic metabolism-related specialization. Intracellular lipid accumulation achieved through loading the cells with free fatty acids (FFA, 2:1 oleic:palmitic acid), differently affected the four subgroups. Moreover, we have shown that intracellular fat accumulation diminishes the drug-related metabolic capacity of hepatocytes.
2023-09-19 | E-MTAB-11530 | biostudies-arrayexpress
Project description:The aim of the study was to characterize at a molecular level (changes in mRNA level) the effects of WNT3A on the human HepaRG hepatocellular carcinoma cell line. This was adressed by culturing HepaRG cells in presence or absence of Wnt3a.
2017-02-11 | GSE68633 | GEO
Project description:In order to identify molecular mechanisms associated with PNPLA3 associated non-alcoholic fatty liver disease, we ran RNA sequencing on human induced pluripotent stem cell-derived hepatocyte like cells that were homozygous for the wild type PNPLA3 allele, homozygous for the risk PNPLA3 allele (I148M), or had a complete knock-out of the PNPLA3 gene. The cells were then treated with either oleic acid or palmitic acid to induce a steatotic or a lipotoxic phenotype, respectively. The cells were treated with control medium or medium supplemented with 0.25 mM oleic acid or palmitic acid for 24 hours before samples were collected for RNA sequencing.
2021-09-10 | GSE158182 | GEO
Project description:HepaRG cell, a stabilized bipotent liver progenitor cell line, exhibits hepatocyte functions only after differentiation. However, the mechanism of transition from non-differentiated to differentiated states, accompanied by proliferation and migration, is poorly understood. Little information exists for proteins involved in this process, particularly those residing in the plasma membrane. In this study, the plasma membrane protein expression change of HepaRG cell before and after differentiation were systematically analyzed using an iTRAQ labeled quantitative membrane proteomics approach. A total of 70 membrane proteins were identified to be differentially expressed. Function and disease clustering analysis showed that 11 of these proteins are involved in migration. Two key factors (MMP-14 and OCLN) were validated by qRT-PCR and Western Blot. Blockade of MMP-14, an extracellular matrix metalloprotease, by monoclonal antibody in a wound healing assay further demonstrated the importance of this protein in tumor cell migration. Even further, the MMP-14 expression correlation with HCC is confirmed by HCC cell lines and tissue samples.
2017-02-08 | PXD004752 | Pride
Project description:During embryonic development DNA methylation is highly dynamic, although less is known about the stability and fine-tuning of DNA methylation at later stages of differentiation. To understand the role of DNA methylation during hepatocyte differentiation, we profiled approximately 450k methylation sites at different time points in the progression from hepatoblast to hepatocyte stages using the bipotent liver progenitor HepaRG cell line. Progressive demethylation of HNF4A P1 was highly correlated with increased expression of the shorter isoforms of HNF4A. In addition, the absence of cell division at later stages of differentiation and the increased expression of TET1 and TET2 transcripts indicates that a process of active demethylation is taking place at this specific locus. These data suggest that liver progenitors are poised for targeted demethylation at specific genomic locations involved in terminal stages of hepatocyte differentiation.
2017-07-22 | GSE72074 | GEO
Project description:Primary hepatocytes are widely utilized for investigating drug efficacy and toxicity, yet variations between batches and limited proliferation capacity present significant challenges. HepaRG cells are versatile cells, capable of maintaining an undifferentiated state and differentiating through dimethyl sulfoxide treatment, allowing for molecular analysis of hepatocyte plasticity. To elucidate the underlying molecular mechanisms of HepaRG cell plasticity, we used CYP3A4G/7R HepaRG cells engineered to express DsRed under the control of the fetus-specific CYP3A7 gene and EGFP under the adult-specific CYP3A4 gene promoter. In time-lapse imaging of CYP3A4G/7R HepaRG cells, we observed CYP3A7-DsRed expression transitioning from negative to positive during proliferation period and CYP3A4-GFP expression activating during differentiation. The de-differentiation potency of differentiated CYP3A4G/7R HepaRG cells was assessed using inhibitors and cytokines. It was found that Y-27632 (Y), A-83-01 (A), and CHIR99021 (C) (collectively referred to as YAC), which are known to promote liver regeneration in mice, did not induce CYP3A7-DsRed expression. Instead, these inhibitors increased CYP3A4-GFP expressing population. Furthermore, CHIR99021 alone increased CYP3A4-GFP-positive cells, while Wnt3a treatment increased CYP3A7-DsRed-positive cells, suggesting that Wnt signaling plays distinct roles in HepaRG cells. It was apparent that de-differentiated cells had increased CYP3A4 activity after a second round of differentiation, compared to differentiated cells after the first round. Transcriptomic analysis of HepaRG cells revealed distinct profiles between proliferative, differentiated, and de-differentiated states, highlighting their robust plasticity. Notably, hepatoblastic cells de-differentiated by YAC or C displayed transcriptome patterns similar to undifferentiated cells, whereas CYP3A7-DsRed and CYP3A4-GFP exhibited expression patterns different from those of undifferentiated cells. These findings underscore the dynamic nature of HepaRG cells while cautioning against solely relying on CYP3 family gene expression as a marker of differentiation.
2024-09-18 | GSE272892 | GEO
Project description:According with the hepatic protection role of Vitamin E (VE), clinical guidelines of gastroenterology societies are now supporting the administration of VE as first line treatment of Non-Alcoholic SteatoHepatitis (NASH). We used microarrays to detail the transcriptional response obtained by pre-administration to HepaRG cell line of different sources of VE (WGO-VE, nVE and sVE) followed by exposure to oleic acid (OA) to induce conditions of steatosis
2022-01-30 | GSE195619 | GEO
Project description:The exposure to and contamination by Persistent Organic Pollutants (POPs), which include pesticides used worldwide and polyaromatic hydrocarbons, is detrimental to human health and diverse ecosystems. Although most mechanistic studies have focused on single compounds, living organisms are exposed to multiple environmental xenobiotics, simultaneously, throughout their lives. The experimental evidence useful for assessing the effects of exposure to pollutant mixtures is scarce. We investigated the effects of exposure to a combination of two POPs, which employ different xenosensors, on global gene expression in a human hepatocyte cell model, HepaRG. Whole genome microarrays were used to investigate the effects on the HepaRG transcriptome following exposure to the combination of POPs as compared to each compound individually. Differentiated HepaRG cells were treated with either 2,3,7,8 tetrachlorodibenzo-p-dioxin, alpha-endosulfan (an organochlorine pesticide), the mixture or the DMSO vehicle for 30 hours after which RNA was extracted for hybridization on Affymetrix whole human genome microarrays.
2016-07-03 | E-GEOD-46874 | biostudies-arrayexpress
Project description:The present study was aimed to mimic steatosis in in-vitro HepaRG model and test the effect of lipid loading on drug metabolizing enzymes and transporters (DMET) in steatosis. HepaRG cells, differentiated in-house were exposed to mixture of saturated and unsaturated fatty acids, 0.5 mM palmitate and oleate (1:2) conjugated to BSA (0.02%) for 72h. Following the incubation, the model system was characterized using ORO staining for neutral lipids, tested for toxicity with WST-1 assay and triglyceride (TAG) accumulation was measured using TAG calorimetric assay. Increased lipid accumulation and 6-fold increase in TAG was observed (P < 0.05, n=4). The whole transcriptome was analyzed using RNA sequencing. Differentially expressed transcripts were identified upon FA treatment versus (vs.) control in HepaRG cell line (393 total transcripts, 89 up- and 304 downregulated). Lipid loading, led to significant down-regulation in gene expression levels of various DMET, nuclear receptors and transcription factors such as CYP3A4, 1A2, 2B6, 2C8, 2C9 and 2C19, along with this UGT1A9, UGT1A6, ABCB1, NR1I2 and HNF4α (P < 0.05, n=3). The accumulation of saturated and polyunsaturated fatty acids may selectively inhibit certain DME pathways.
2020-12-31 | GSE122151 | GEO